

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | response to muramyl dipeptide (GO:0032495) | 4.67400501 |
| 2 | endothelial cell chemotaxis (GO:0035767) | 3.84820634 |
| 3 | mannose metabolic process (GO:0006013) | 3.83382204 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.46588294 |
| 5 | germinal center formation (GO:0002467) | 3.42987358 |
| 6 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.36486815 |
| 7 | negative thymic T cell selection (GO:0045060) | 3.36447994 |
| 8 | sodium ion export (GO:0071436) | 3.17318124 |
| 9 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 3.15756404 |
| 10 | negative T cell selection (GO:0043383) | 3.15555007 |
| 11 | histone H3-K36 demethylation (GO:0070544) | 3.14859182 |
| 12 | embryonic process involved in female pregnancy (GO:0060136) | 3.11715456 |
| 13 | regulation of ARF protein signal transduction (GO:0032012) | 2.96676429 |
| 14 | cellular response to fluid shear stress (GO:0071498) | 2.95952318 |
| 15 | regulation of germinal center formation (GO:0002634) | 2.95293630 |
| 16 | cellular response to epinephrine stimulus (GO:0071872) | 2.93600947 |
| 17 | positive regulation of histone deacetylation (GO:0031065) | 2.93493880 |
| 18 | positive thymic T cell selection (GO:0045059) | 2.84953569 |
| 19 | synaptic vesicle maturation (GO:0016188) | 2.84403575 |
| 20 | histone H3-K9 demethylation (GO:0033169) | 2.83649194 |
| 21 | histone demethylation (GO:0016577) | 2.81006927 |
| 22 | histone lysine demethylation (GO:0070076) | 2.80950081 |
| 23 | negative regulation of bone resorption (GO:0045779) | 2.80320980 |
| 24 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.79497277 |
| 25 | locomotory exploration behavior (GO:0035641) | 2.78109882 |
| 26 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.77497015 |
| 27 | positive regulation of p38MAPK cascade (GO:1900745) | 2.71198618 |
| 28 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.66815661 |
| 29 | negative regulation of inclusion body assembly (GO:0090084) | 2.62577101 |
| 30 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.61289531 |
| 31 | growth hormone receptor signaling pathway (GO:0060396) | 2.59734812 |
| 32 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.59543299 |
| 33 | regulation of ARF GTPase activity (GO:0032312) | 2.57631601 |
| 34 | definitive hemopoiesis (GO:0060216) | 2.56789679 |
| 35 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.52610837 |
| 36 | * regulation of p38MAPK cascade (GO:1900744) | 2.52185387 |
| 37 | regulation of gamma-delta T cell activation (GO:0046643) | 2.51828857 |
| 38 | negative regulation of skeletal muscle tissue development (GO:0048642) | 2.51793345 |
| 39 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.51742303 |
| 40 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.51715950 |
| 41 | RNA destabilization (GO:0050779) | 2.49716913 |
| 42 | detection of bacterium (GO:0016045) | 2.49560608 |
| 43 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.49060026 |
| 44 | regulation of synapse structural plasticity (GO:0051823) | 2.47971418 |
| 45 | positive regulation of Rap GTPase activity (GO:0032854) | 2.47846697 |
| 46 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.47801686 |
| 47 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.47387176 |
| 48 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.46801638 |
| 49 | B cell homeostasis (GO:0001782) | 2.45868450 |
| 50 | protein localization to endosome (GO:0036010) | 2.44192257 |
| 51 | regulation of histone H3-K27 methylation (GO:0061085) | 2.44040704 |
| 52 | thymic T cell selection (GO:0045061) | 2.44001122 |
| 53 | establishment of endothelial barrier (GO:0061028) | 2.42270208 |
| 54 | negative regulation of interleukin-2 production (GO:0032703) | 2.41984387 |
| 55 | regulation of granulocyte differentiation (GO:0030852) | 2.41704868 |
| 56 | response to peptidoglycan (GO:0032494) | 2.41059689 |
| 57 | negative regulation of smooth muscle cell proliferation (GO:0048662) | 2.39968719 |
| 58 | stress fiber assembly (GO:0043149) | 2.39759699 |
| 59 | detection of other organism (GO:0098543) | 2.39711885 |
| 60 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.38676139 |
| 61 | activation of MAPKKK activity (GO:0000185) | 2.38362340 |
| 62 | protein dealkylation (GO:0008214) | 2.38009332 |
| 63 | protein demethylation (GO:0006482) | 2.38009332 |
| 64 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.37990386 |
| 65 | activation of protein kinase A activity (GO:0034199) | 2.37222469 |
| 66 | negative regulation of innate immune response (GO:0045824) | 2.36882557 |
| 67 | positive regulation of granulocyte differentiation (GO:0030854) | 2.36876030 |
| 68 | regulation of cell migration involved in sprouting angiogenesis (GO:0090049) | 2.35827191 |
| 69 | cellular extravasation (GO:0045123) | 2.35165189 |
| 70 | positive regulation of extracellular matrix organization (GO:1903055) | 2.34935266 |
| 71 | nerve growth factor signaling pathway (GO:0038180) | 2.34472465 |
| 72 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.34182704 |
| 73 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.32964382 |
| 74 | regulation of cholesterol homeostasis (GO:2000188) | 2.32918661 |
| 75 | cell communication by electrical coupling (GO:0010644) | 2.32829065 |
| 76 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.32666771 |
| 77 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.32664314 |
| 78 | response to epinephrine (GO:0071871) | 2.32317396 |
| 79 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.31738287 |
| 80 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.31399225 |
| 81 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.31335511 |
| 82 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.30744787 |
| 83 | creatine metabolic process (GO:0006600) | 2.29953772 |
| 84 | histone H3-K4 trimethylation (GO:0080182) | 2.29723710 |
| 85 | negative regulation of myotube differentiation (GO:0010832) | 2.28761258 |
| 86 | regulation of monocyte differentiation (GO:0045655) | 2.28725847 |
| 87 | negative regulation of interleukin-6 production (GO:0032715) | 2.28601362 |
| 88 | Peyers patch development (GO:0048541) | 2.28092830 |
| 89 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.28092830 |
| 90 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.27775998 |
| 91 | positive T cell selection (GO:0043368) | 2.27556524 |
| 92 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.27189300 |
| 93 | negative regulation of cell killing (GO:0031342) | 2.27189300 |
| 94 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.26191649 |
| 95 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.26191649 |
| 96 | positive regulation of protein deacetylation (GO:0090312) | 2.25731267 |
| 97 | leukocyte aggregation (GO:0070486) | 2.24999494 |
| 98 | positive regulation of cholesterol efflux (GO:0010875) | 2.24980552 |
| 99 | cellular response to growth hormone stimulus (GO:0071378) | 2.22853937 |
| 100 | atrioventricular valve morphogenesis (GO:0003181) | 2.22300971 |
| 101 | negative regulation of interleukin-8 production (GO:0032717) | 2.20821457 |
| 102 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.20628072 |
| 103 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.20472127 |
| 104 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.20257384 |
| 105 | regulation of Rap GTPase activity (GO:0032317) | 2.20177426 |
| 106 | macroautophagy (GO:0016236) | 2.19658293 |
| 107 | establishment of protein localization to Golgi (GO:0072600) | 2.19517815 |
| 108 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.19343086 |
| 109 | megakaryocyte development (GO:0035855) | 2.18032521 |
| 110 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.17557713 |
| 111 | plasma membrane repair (GO:0001778) | 2.17473059 |
| 112 | histone H3-K9 modification (GO:0061647) | 2.17362871 |
| 113 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.16818584 |
| 114 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.16789350 |
| 115 | potassium ion import (GO:0010107) | 2.16653357 |
| 116 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.15644341 |
| 117 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.15514255 |
| 118 | positive regulation of B cell differentiation (GO:0045579) | 2.15478346 |
| 119 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.14918093 |
| 120 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.13740286 |
| 121 | protein targeting to Golgi (GO:0000042) | 2.11675345 |
| 122 | establishment of nucleus localization (GO:0040023) | 2.11598180 |
| 123 | response to laminar fluid shear stress (GO:0034616) | 2.10846937 |
| 124 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.09574494 |
| 125 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.05365052 |
| 126 | cardiac myofibril assembly (GO:0055003) | 2.04929577 |
| 127 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.02995991 |
| 128 | blood vessel endothelial cell migration (GO:0043534) | 2.01601843 |
| 129 | cellular potassium ion homeostasis (GO:0030007) | 2.01446689 |
| 130 | layer formation in cerebral cortex (GO:0021819) | 2.01438514 |
| 131 | cell communication involved in cardiac conduction (GO:0086065) | 2.00686659 |
| 132 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.00521289 |
| 133 | T cell selection (GO:0045058) | 1.99656082 |
| 134 | apoptotic cell clearance (GO:0043277) | 1.98034560 |
| 135 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 1.96845030 |
| 136 | tolerance induction (GO:0002507) | 1.96745424 |
| 137 | cAMP biosynthetic process (GO:0006171) | 1.96491935 |
| 138 | carnitine shuttle (GO:0006853) | 1.95668336 |
| 139 | regulation of neuronal synaptic plasticity (GO:0048168) | 1.94933821 |
| 140 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 1.94788430 |
| 141 | relaxation of cardiac muscle (GO:0055119) | 1.94077519 |
| 142 | response to isoquinoline alkaloid (GO:0014072) | 1.93828776 |
| 143 | regulation of fatty acid beta-oxidation (GO:0031998) | 1.92673077 |
| 144 | adenosine receptor signaling pathway (GO:0001973) | 1.90645681 |
| 145 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 1.90553695 |
| 146 | positive regulation of glycogen metabolic process (GO:0070875) | 1.88528779 |
| 147 | positive regulation of fatty acid oxidation (GO:0046321) | 1.88355210 |
| 148 | regulation of T cell tolerance induction (GO:0002664) | 1.87984719 |
| 149 | vocalization behavior (GO:0071625) | 1.87723946 |
| 150 | negative regulation of granulocyte differentiation (GO:0030853) | 1.87411359 |
| 151 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 1.86392804 |
| 152 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 1.85144642 |
| 153 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 1.85122838 |
| 154 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 1.84661699 |
| 155 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 1.84409112 |
| 156 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 1.84409112 |
| 157 | cytoplasmic mRNA processing body assembly (GO:0033962) | 1.84268754 |
| 158 | activation of JUN kinase activity (GO:0007257) | 1.83305494 |
| 159 | response to fluid shear stress (GO:0034405) | 1.82780191 |
| 160 | surfactant homeostasis (GO:0043129) | 1.82541675 |
| 161 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 1.81732122 |
| 162 | regulation of glutamate receptor signaling pathway (GO:1900449) | 1.80553856 |
| 163 | venous blood vessel morphogenesis (GO:0048845) | 1.80184787 |
| 164 | negative regulation of fatty acid transport (GO:2000192) | 1.80148593 |
| 165 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 1.79778333 |
| 166 | negative regulation of heart growth (GO:0061117) | 1.79778333 |
| 167 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 1.79657720 |
| 168 | coronary vasculature morphogenesis (GO:0060977) | 1.77788808 |
| 169 | sarcomere organization (GO:0045214) | 1.77476470 |
| 170 | response to morphine (GO:0043278) | 1.76631135 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.62268326 |
| 2 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.56201851 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.52621496 |
| 4 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.29225228 |
| 5 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.11323025 |
| 6 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.02008272 |
| 7 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.97490272 |
| 8 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.95187935 |
| 9 | KDM2B_26808549_Chip-Seq_K562_Human | 1.94589417 |
| 10 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.93925963 |
| 11 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.91490749 |
| 12 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.84877604 |
| 13 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.84156804 |
| 14 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.78993358 |
| 15 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.72349636 |
| 16 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.70939023 |
| 17 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.70545671 |
| 18 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.70523418 |
| 19 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.68631226 |
| 20 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.68289991 |
| 21 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.66607714 |
| 22 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.66297131 |
| 23 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.61071351 |
| 24 | * CLOCK_20551151_ChIP-Seq_293T_Human | 1.60439434 |
| 25 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.58806817 |
| 26 | * MAF_26560356_Chip-Seq_TH2_Human | 1.56683804 |
| 27 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.55846784 |
| 28 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.54776087 |
| 29 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.53836708 |
| 30 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.53441920 |
| 31 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.53268088 |
| 32 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.52349068 |
| 33 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.51020908 |
| 34 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.50988263 |
| 35 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.50407814 |
| 36 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.46569901 |
| 37 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.42632143 |
| 38 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.41911773 |
| 39 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.41573200 |
| 40 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.41471987 |
| 41 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.40409564 |
| 42 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.40233891 |
| 43 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.40138614 |
| 44 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.38495359 |
| 45 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.37849277 |
| 46 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.37548444 |
| 47 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.37495837 |
| 48 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35940170 |
| 49 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.35644061 |
| 50 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.34534844 |
| 51 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.33761462 |
| 52 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.33685923 |
| 53 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.32781432 |
| 54 | * MYC_22102868_ChIP-Seq_BL_Human | 1.31874453 |
| 55 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.31223534 |
| 56 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.31223534 |
| 57 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.30608866 |
| 58 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.29351361 |
| 59 | * MYB_26560356_Chip-Seq_TH2_Human | 1.28498344 |
| 60 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.27650403 |
| 61 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.27575855 |
| 62 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.27046959 |
| 63 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.26767454 |
| 64 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.26509868 |
| 65 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.26157630 |
| 66 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.25523466 |
| 67 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.24690424 |
| 68 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.24209179 |
| 69 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.24056426 |
| 70 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.22814146 |
| 71 | * MYB_26560356_Chip-Seq_TH1_Human | 1.22703896 |
| 72 | * P68_20966046_ChIP-Seq_HELA_Human | 1.22343252 |
| 73 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.21904044 |
| 74 | GATA1_19941826_ChIP-Seq_K562_Human | 1.21337479 |
| 75 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.21271394 |
| 76 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.20796171 |
| 77 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.18643442 |
| 78 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.18094248 |
| 79 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.18094248 |
| 80 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.16060838 |
| 81 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.14396055 |
| 82 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.14296171 |
| 83 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.13213503 |
| 84 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.13007173 |
| 85 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.12920422 |
| 86 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.12222855 |
| 87 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.11230861 |
| 88 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.11080109 |
| 89 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.10533799 |
| 90 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.09874439 |
| 91 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09691266 |
| 92 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.08589376 |
| 93 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.07486065 |
| 94 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.06981536 |
| 95 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.06972647 |
| 96 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.06758873 |
| 97 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.05713386 |
| 98 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.05569264 |
| 99 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.05212592 |
| 100 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.05168237 |
| 101 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.04553240 |
| 102 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04322758 |
| 103 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.04227461 |
| 104 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.04145131 |
| 105 | SPI1_23127762_ChIP-Seq_K562_Human | 1.03362335 |
| 106 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.02480010 |
| 107 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.02467517 |
| 108 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.02162384 |
| 109 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.01496270 |
| 110 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.01414417 |
| 111 | * MAF_26560356_Chip-Seq_TH1_Human | 1.01295670 |
| 112 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.00785200 |
| 113 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.99703380 |
| 114 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.99683411 |
| 115 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.99287594 |
| 116 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98674510 |
| 117 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.98182378 |
| 118 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.97954774 |
| 119 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.95448812 |
| 120 | GATA2_19941826_ChIP-Seq_K562_Human | 0.95366267 |
| 121 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.95232135 |
| 122 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.95030901 |
| 123 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94419622 |
| 124 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.93646211 |
| 125 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.93400244 |
| 126 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.93248711 |
| 127 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.91443688 |
| 128 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91075026 |
| 129 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.90827740 |
| 130 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.89939320 |
| 131 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.89541647 |
| 132 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.89418050 |
| 133 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.89254015 |
| 134 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.88635103 |
| 135 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.87693419 |
| 136 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.87230098 |
| 137 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.86982294 |
| 138 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.86432789 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004510_myositis | 3.57622155 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 3.26514117 |
| 3 | * MP0008961_abnormal_basal_metabolism | 3.04444363 |
| 4 | MP0002009_preneoplasia | 2.82490558 |
| 5 | MP0005670_abnormal_white_adipose | 2.69504082 |
| 6 | MP0003763_abnormal_thymus_physiology | 2.59634422 |
| 7 | MP0003300_gastrointestinal_ulcer | 2.46720565 |
| 8 | MP0003303_peritoneal_inflammation | 2.34717374 |
| 9 | MP0002933_joint_inflammation | 2.27649845 |
| 10 | MP0000751_myopathy | 2.15525496 |
| 11 | MP0002837_dystrophic_cardiac_calcinosis | 2.14261692 |
| 12 | MP0004130_abnormal_muscle_cell | 2.11715780 |
| 13 | MP0004084_abnormal_cardiac_muscle | 2.01049115 |
| 14 | MP0003045_fibrosis | 1.92644071 |
| 15 | MP0005423_abnormal_somatic_nervous | 1.91961407 |
| 16 | MP0005167_abnormal_blood-brain_barrier | 1.85377336 |
| 17 | MP0003828_pulmonary_edema | 1.83973987 |
| 18 | MP0002909_abnormal_adrenal_gland | 1.78467166 |
| 19 | MP0001853_heart_inflammation | 1.78174090 |
| 20 | MP0003075_altered_response_to | 1.75390010 |
| 21 | MP0009840_abnormal_foam_cell | 1.71651090 |
| 22 | MP0005375_adipose_tissue_phenotype | 1.71545252 |
| 23 | MP0001545_abnormal_hematopoietic_system | 1.70593087 |
| 24 | MP0005397_hematopoietic_system_phenotyp | 1.70593087 |
| 25 | MP0004036_abnormal_muscle_relaxation | 1.69717034 |
| 26 | MP0005666_abnormal_adipose_tissue | 1.68654683 |
| 27 | MP0005000_abnormal_immune_tolerance | 1.68601846 |
| 28 | MP0001800_abnormal_humoral_immune | 1.65313964 |
| 29 | MP0004185_abnormal_adipocyte_glucose | 1.64064377 |
| 30 | MP0005076_abnormal_cell_differentiation | 1.59860669 |
| 31 | MP0003191_abnormal_cellular_cholesterol | 1.58901136 |
| 32 | MP0002254_reproductive_system_inflammat | 1.55562397 |
| 33 | MP0008260_abnormal_autophagy | 1.54754976 |
| 34 | MP0004087_abnormal_muscle_fiber | 1.54364777 |
| 35 | MP0010368_abnormal_lymphatic_system | 1.53618397 |
| 36 | MP0009780_abnormal_chondrocyte_physiolo | 1.53110265 |
| 37 | MP0002419_abnormal_innate_immunity | 1.52514915 |
| 38 | MP0001533_abnormal_skeleton_physiology | 1.52164504 |
| 39 | MP0001873_stomach_inflammation | 1.50581493 |
| 40 | MP0003635_abnormal_synaptic_transmissio | 1.46666288 |
| 41 | MP0003705_abnormal_hypodermis_morpholog | 1.45595312 |
| 42 | MP0009278_abnormal_bone_marrow | 1.45458127 |
| 43 | MP0000013_abnormal_adipose_tissue | 1.43551892 |
| 44 | MP0005451_abnormal_body_composition | 1.43474775 |
| 45 | MP0000465_gastrointestinal_hemorrhage | 1.42044549 |
| 46 | MP0002822_catalepsy | 1.42017368 |
| 47 | MP0005058_abnormal_lysosome_morphology | 1.41094886 |
| 48 | MP0003329_amyloid_beta_deposits | 1.40349229 |
| 49 | MP0000003_abnormal_adipose_tissue | 1.37022359 |
| 50 | MP0002723_abnormal_immune_serum | 1.36693696 |
| 51 | MP0002420_abnormal_adaptive_immunity | 1.35766030 |
| 52 | MP0004145_abnormal_muscle_electrophysio | 1.35264725 |
| 53 | MP0008569_lethality_at_weaning | 1.32986158 |
| 54 | MP0001819_abnormal_immune_cell | 1.32681718 |
| 55 | MP0003656_abnormal_erythrocyte_physiolo | 1.31858082 |
| 56 | MP0005025_abnormal_response_to | 1.30751020 |
| 57 | MP0001851_eye_inflammation | 1.28666089 |
| 58 | MP0003690_abnormal_glial_cell | 1.28583816 |
| 59 | MP0005409_darkened_coat_color | 1.28461466 |
| 60 | MP0004381_abnormal_hair_follicle | 1.27793519 |
| 61 | MP0010630_abnormal_cardiac_muscle | 1.27727139 |
| 62 | MP0005330_cardiomyopathy | 1.26843561 |
| 63 | MP0002452_abnormal_antigen_presenting | 1.25275863 |
| 64 | MP0009333_abnormal_splenocyte_physiolog | 1.23338173 |
| 65 | MP0003183_abnormal_peptide_metabolism | 1.22265126 |
| 66 | MP0002877_abnormal_melanocyte_morpholog | 1.21861493 |
| 67 | MP0004484_altered_response_of | 1.21178728 |
| 68 | MP0002396_abnormal_hematopoietic_system | 1.20446328 |
| 69 | MP0000703_abnormal_thymus_morphology | 1.20169978 |
| 70 | * MP0002398_abnormal_bone_marrow | 1.19638657 |
| 71 | MP0003566_abnormal_cell_adhesion | 1.18082188 |
| 72 | MP0003172_abnormal_lysosome_physiology | 1.17304330 |
| 73 | MP0004947_skin_inflammation | 1.14155498 |
| 74 | MP0000716_abnormal_immune_system | 1.12275981 |
| 75 | MP0004808_abnormal_hematopoietic_stem | 1.12044755 |
| 76 | MP0002971_abnormal_brown_adipose | 1.11432612 |
| 77 | MP0009115_abnormal_fat_cell | 1.11017173 |
| 78 | MP0003279_aneurysm | 1.10154403 |
| 79 | MP0001835_abnormal_antigen_presentation | 1.09232051 |
| 80 | MP0006138_congestive_heart_failure | 1.08547827 |
| 81 | MP0004085_abnormal_heartbeat | 1.08316440 |
| 82 | MP0010155_abnormal_intestine_physiology | 1.07437305 |
| 83 | MP0002063_abnormal_learning/memory/cond | 1.07121748 |
| 84 | MP0002106_abnormal_muscle_physiology | 1.06976832 |
| 85 | * MP0001501_abnormal_sleep_pattern | 1.06862151 |
| 86 | MP0002332_abnormal_exercise_endurance | 1.05400842 |
| 87 | MP0002138_abnormal_hepatobiliary_system | 1.03815589 |
| 88 | MP0003633_abnormal_nervous_system | 1.01895795 |
| 89 | MP0000604_amyloidosis | 1.00879049 |
| 90 | MP0008004_abnormal_stomach_pH | 1.00569343 |
| 91 | MP0004270_analgesia | 1.00240986 |
| 92 | MP0005464_abnormal_platelet_physiology | 0.99227649 |
| 93 | MP0000759_abnormal_skeletal_muscle | 0.99135613 |
| 94 | MP0000749_muscle_degeneration | 0.98867057 |
| 95 | MP0003724_increased_susceptibility_to | 0.98760475 |
| 96 | MP0000750_abnormal_muscle_regeneration | 0.97365162 |
| 97 | MP0005620_abnormal_muscle_contractility | 0.97172767 |
| 98 | MP0002064_seizures | 0.96990423 |
| 99 | MP0008874_decreased_physiological_sensi | 0.96718360 |
| 100 | MP0002722_abnormal_immune_system | 0.96497580 |
| 101 | MP0004858_abnormal_nervous_system | 0.95406799 |
| 102 | MP0001790_abnormal_immune_system | 0.95163002 |
| 103 | MP0005387_immune_system_phenotype | 0.95163002 |
| 104 | MP0001544_abnormal_cardiovascular_syste | 0.94851503 |
| 105 | MP0005385_cardiovascular_system_phenoty | 0.94851503 |
| 106 | MP0009745_abnormal_behavioral_response | 0.94671695 |
| 107 | MP0004215_abnormal_myocardial_fiber | 0.92962038 |
| 108 | * MP0002998_abnormal_bone_remodeling | 0.91773958 |
| 109 | MP0000747_muscle_weakness | 0.91493112 |
| 110 | MP0000685_abnormal_immune_system | 0.90498650 |
| 111 | MP0005390_skeleton_phenotype | 0.90110408 |
| 112 | MP0005166_decreased_susceptibility_to | 0.90048774 |
| 113 | MP0005334_abnormal_fat_pad | 0.89755630 |
| 114 | MP0000733_abnormal_muscle_development | 0.89656945 |
| 115 | MP0003091_abnormal_cell_migration | 0.88800722 |
| 116 | MP0002972_abnormal_cardiac_muscle | 0.88673048 |
| 117 | MP0000689_abnormal_spleen_morphology | 0.88383179 |
| 118 | MP0003436_decreased_susceptibility_to | 0.87922879 |
| 119 | MP0005448_abnormal_energy_balance | 0.86196007 |
| 120 | MP0002429_abnormal_blood_cell | 0.85738906 |
| 121 | MP0001879_abnormal_lymphatic_vessel | 0.84636250 |
| 122 | MP0008775_abnormal_heart_ventricle | 0.84596767 |
| 123 | * MP0001502_abnormal_circadian_rhythm | 0.83919081 |
| 124 | MP0003646_muscle_fatigue | 0.83912067 |
| 125 | MP0002166_altered_tumor_susceptibility | 0.83654068 |
| 126 | MP0001958_emphysema | 0.83077046 |
| 127 | MP0003866_abnormal_defecation | 0.82608289 |
| 128 | MP0000767_abnormal_smooth_muscle | 0.82598071 |
| 129 | MP0005310_abnormal_salivary_gland | 0.82274162 |
| 130 | MP0004885_abnormal_endolymph | 0.82029962 |
| 131 | MP0005369_muscle_phenotype | 0.82002144 |
| 132 | MP0002796_impaired_skin_barrier | 0.80045079 |
| 133 | MP0002089_abnormal_postnatal_growth/wei | 0.79528976 |
| 134 | * MP0005535_abnormal_body_temperature | 0.78613234 |
| 135 | MP0002928_abnormal_bile_duct | 0.78007935 |
| 136 | MP0000249_abnormal_blood_vessel | 0.77961725 |
| 137 | MP0002090_abnormal_vision | 0.74181330 |
| 138 | MP0003137_abnormal_impulse_conducting | 0.73997263 |
| 139 | MP0002269_muscular_atrophy | 0.73818197 |
| 140 | MP0001486_abnormal_startle_reflex | 0.72435873 |
| 141 | MP0002405_respiratory_system_inflammati | 0.71763164 |
| 142 | MP0003453_abnormal_keratinocyte_physiol | 0.70976981 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cerebral aneurysm (HP:0004944) | 3.68809881 |
| 2 | Eczematoid dermatitis (HP:0000976) | 3.49722674 |
| 3 | Hyporeflexia of lower limbs (HP:0002600) | 3.25764439 |
| 4 | Exercise-induced myalgia (HP:0003738) | 3.20822442 |
| 5 | Difficulty running (HP:0009046) | 2.95891749 |
| 6 | Sudden death (HP:0001699) | 2.89527595 |
| 7 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.89507050 |
| 8 | Broad face (HP:0000283) | 2.88968629 |
| 9 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.85386985 |
| 10 | Distal lower limb muscle weakness (HP:0009053) | 2.77853910 |
| 11 | Bundle branch block (HP:0011710) | 2.77212210 |
| 12 | Muscle fiber inclusion bodies (HP:0100299) | 2.71625100 |
| 13 | Broad metatarsal (HP:0001783) | 2.66752961 |
| 14 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.60873538 |
| 15 | Prolonged bleeding time (HP:0003010) | 2.55082474 |
| 16 | Papilledema (HP:0001085) | 2.52228306 |
| 17 | Nemaline bodies (HP:0003798) | 2.51574465 |
| 18 | Dysmetric saccades (HP:0000641) | 2.49441491 |
| 19 | Increased connective tissue (HP:0009025) | 2.48236263 |
| 20 | Muscle fiber splitting (HP:0003555) | 2.46644480 |
| 21 | Round ear (HP:0100830) | 2.46038367 |
| 22 | Hyperacusis (HP:0010780) | 2.44782016 |
| 23 | Increased variability in muscle fiber diameter (HP:0003557) | 2.42255021 |
| 24 | Ulnar deviation of the wrist (HP:0003049) | 2.41124184 |
| 25 | Striae distensae (HP:0001065) | 2.35889432 |
| 26 | Easy fatigability (HP:0003388) | 2.34421798 |
| 27 | Asymmetric septal hypertrophy (HP:0001670) | 2.34280216 |
| 28 | Aortic aneurysm (HP:0004942) | 2.29399036 |
| 29 | Polycythemia (HP:0001901) | 2.28075521 |
| 30 | Myopathic facies (HP:0002058) | 2.27382610 |
| 31 | Pustule (HP:0200039) | 2.26251781 |
| 32 | Macroorchidism (HP:0000053) | 2.24329333 |
| 33 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.23344741 |
| 34 | Neoplasm of the heart (HP:0100544) | 2.20659133 |
| 35 | Spinal canal stenosis (HP:0003416) | 2.19256937 |
| 36 | Aneurysm (HP:0002617) | 2.17510175 |
| 37 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.17296326 |
| 38 | Arterial tortuosity (HP:0005116) | 2.17290703 |
| 39 | Ventricular fibrillation (HP:0001663) | 2.15395566 |
| 40 | Mitral valve prolapse (HP:0001634) | 2.15079462 |
| 41 | Abnormality of binocular vision (HP:0011514) | 2.14112280 |
| 42 | Diplopia (HP:0000651) | 2.14112280 |
| 43 | Peripheral hypomyelination (HP:0007182) | 2.13942789 |
| 44 | Myositis (HP:0100614) | 2.13577727 |
| 45 | Dislocated radial head (HP:0003083) | 2.13018773 |
| 46 | Distal upper limb amyotrophy (HP:0007149) | 2.11924869 |
| 47 | Upper limb amyotrophy (HP:0009129) | 2.11924869 |
| 48 | Heart block (HP:0012722) | 2.10097567 |
| 49 | Lower limb amyotrophy (HP:0007210) | 2.08647658 |
| 50 | Slow saccadic eye movements (HP:0000514) | 2.08263718 |
| 51 | Supranuclear gaze palsy (HP:0000605) | 2.07613158 |
| 52 | Hemiplegia (HP:0002301) | 2.07385937 |
| 53 | Prolonged QT interval (HP:0001657) | 2.07379742 |
| 54 | Abnormal atrioventricular conduction (HP:0005150) | 2.06724573 |
| 55 | Rapidly progressive (HP:0003678) | 2.06014167 |
| 56 | Right ventricular cardiomyopathy (HP:0011663) | 2.04824695 |
| 57 | Polygenic inheritance (HP:0010982) | 2.03255972 |
| 58 | Distal lower limb amyotrophy (HP:0008944) | 2.02894386 |
| 59 | Hyperkalemia (HP:0002153) | 2.02651657 |
| 60 | Abnormality of the radial head (HP:0003995) | 2.02407549 |
| 61 | Type 1 muscle fiber predominance (HP:0003803) | 2.01924636 |
| 62 | Facial diplegia (HP:0001349) | 2.01923872 |
| 63 | Atrioventricular block (HP:0001678) | 2.00679867 |
| 64 | Abnormality of the nasal mucosa (HP:0000433) | 1.99937189 |
| 65 | Spontaneous hematomas (HP:0007420) | 1.99683034 |
| 66 | Atrial fibrillation (HP:0005110) | 1.99477312 |
| 67 | Primary atrial arrhythmia (HP:0001692) | 1.99100254 |
| 68 | Ventricular tachycardia (HP:0004756) | 1.99083754 |
| 69 | Papilloma (HP:0012740) | 1.98698352 |
| 70 | Verrucae (HP:0200043) | 1.98698352 |
| 71 | Gastrointestinal inflammation (HP:0004386) | 1.98353232 |
| 72 | Persistence of primary teeth (HP:0006335) | 1.96776375 |
| 73 | Hematochezia (HP:0002573) | 1.96340362 |
| 74 | Onion bulb formation (HP:0003383) | 1.94796188 |
| 75 | Vascular tortuosity (HP:0004948) | 1.94444063 |
| 76 | Dysostosis multiplex (HP:0000943) | 1.93180683 |
| 77 | Cellulitis (HP:0100658) | 1.93164816 |
| 78 | Epistaxis (HP:0000421) | 1.92985213 |
| 79 | Inflammation of the large intestine (HP:0002037) | 1.92523478 |
| 80 | Elfin facies (HP:0004428) | 1.91877660 |
| 81 | Panhypogammaglobulinemia (HP:0003139) | 1.91785098 |
| 82 | Frequent falls (HP:0002359) | 1.91565456 |
| 83 | Abnormality of the fingertips (HP:0001211) | 1.91163952 |
| 84 | Genetic anticipation (HP:0003743) | 1.90330069 |
| 85 | Neck muscle weakness (HP:0000467) | 1.90326312 |
| 86 | Neonatal hypoglycemia (HP:0001998) | 1.90116566 |
| 87 | Syncope (HP:0001279) | 1.89429091 |
| 88 | Disproportionate tall stature (HP:0001519) | 1.88776293 |
| 89 | Chest pain (HP:0100749) | 1.87910161 |
| 90 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.87835286 |
| 91 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.87713622 |
| 92 | Focal seizures (HP:0007359) | 1.87158620 |
| 93 | Amyloidosis (HP:0011034) | 1.86516239 |
| 94 | EMG: myopathic abnormalities (HP:0003458) | 1.86134548 |
| 95 | Stridor (HP:0010307) | 1.85613430 |
| 96 | Fatigue (HP:0012378) | 1.85348637 |
| 97 | Hypercortisolism (HP:0001578) | 1.84748360 |
| 98 | Abnormality of the columella (HP:0009929) | 1.83891622 |
| 99 | Shallow orbits (HP:0000586) | 1.83692948 |
| 100 | Narrow palate (HP:0000189) | 1.83100807 |
| 101 | Calf muscle hypertrophy (HP:0008981) | 1.83024965 |
| 102 | Joint stiffness (HP:0001387) | 1.83004514 |
| 103 | Rhabdomyolysis (HP:0003201) | 1.82951292 |
| 104 | Hypertriglyceridemia (HP:0002155) | 1.82931872 |
| 105 | Foot dorsiflexor weakness (HP:0009027) | 1.82603231 |
| 106 | Seborrheic dermatitis (HP:0001051) | 1.82576145 |
| 107 | Gastrointestinal infarctions (HP:0005244) | 1.81893054 |
| 108 | Myoglobinuria (HP:0002913) | 1.81804075 |
| 109 | Supraventricular arrhythmia (HP:0005115) | 1.80582814 |
| 110 | Supraventricular tachycardia (HP:0004755) | 1.79416804 |
| 111 | Abnormality of the calf musculature (HP:0001430) | 1.78938519 |
| 112 | Difficulty climbing stairs (HP:0003551) | 1.78557283 |
| 113 | Abnormality of the foot musculature (HP:0001436) | 1.78479673 |
| 114 | Growth hormone excess (HP:0000845) | 1.77805562 |
| 115 | Bulbar palsy (HP:0001283) | 1.77744567 |
| 116 | Subaortic stenosis (HP:0001682) | 1.77564872 |
| 117 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.77564872 |
| 118 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.77240479 |
| 119 | Abnormality of the lower motor neuron (HP:0002366) | 1.76904587 |
| 120 | Increased IgE level (HP:0003212) | 1.76810256 |
| 121 | Visual hallucinations (HP:0002367) | 1.76725642 |
| 122 | Depression (HP:0000716) | 1.76398635 |
| 123 | Obstructive sleep apnea (HP:0002870) | 1.76384097 |
| 124 | Increased density of long bones (HP:0006392) | 1.76183952 |
| 125 | Postural instability (HP:0002172) | 1.76131292 |
| 126 | Urethral obstruction (HP:0000796) | 1.75981312 |
| 127 | Sleep apnea (HP:0010535) | 1.75846772 |
| 128 | Supernumerary ribs (HP:0005815) | 1.75610795 |
| 129 | Gingivitis (HP:0000230) | 1.73250333 |
| 130 | Agammaglobulinemia (HP:0004432) | 1.72407416 |
| 131 | Exercise-induced muscle cramps (HP:0003710) | 1.72246749 |
| 132 | Recurrent fungal infections (HP:0002841) | 1.71928024 |
| 133 | Emphysema (HP:0002097) | 1.71038448 |
| 134 | Complement deficiency (HP:0004431) | 1.70602213 |
| 135 | Abnormality of complement system (HP:0005339) | 1.70551111 |
| 136 | Insomnia (HP:0100785) | 1.70293790 |
| 137 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.69979679 |
| 138 | Meningitis (HP:0001287) | 1.69669696 |
| 139 | Myotonia (HP:0002486) | 1.69569699 |
| 140 | Ventricular arrhythmia (HP:0004308) | 1.69565493 |
| 141 | Stomatitis (HP:0010280) | 1.69442526 |
| 142 | Abnormal eating behavior (HP:0100738) | 1.69176158 |
| 143 | Systemic lupus erythematosus (HP:0002725) | 1.69038066 |
| 144 | Gastrointestinal stroma tumor (HP:0100723) | 1.68410196 |
| 145 | Action tremor (HP:0002345) | 1.67732921 |
| 146 | Mediastinal lymphadenopathy (HP:0100721) | 1.67532281 |
| 147 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.67531289 |
| 148 | Achilles tendon contracture (HP:0001771) | 1.67444746 |
| 149 | Long toe (HP:0010511) | 1.67092525 |
| 150 | Colitis (HP:0002583) | 1.66792666 |
| 151 | Mucopolysacchariduria (HP:0008155) | 1.66187227 |
| 152 | Bronchomalacia (HP:0002780) | 1.65064267 |
| 153 | Increased CSF protein (HP:0002922) | 1.64518038 |
| 154 | Neuronal loss in central nervous system (HP:0002529) | 1.64242359 |
| 155 | Cerebral inclusion bodies (HP:0100314) | 1.63626652 |
| 156 | EMG: neuropathic changes (HP:0003445) | 1.63425445 |
| 157 | Neurofibrillary tangles (HP:0002185) | 1.62430234 |
| 158 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.61362130 |
| 159 | Myocardial infarction (HP:0001658) | 1.61175638 |
| 160 | Sudden cardiac death (HP:0001645) | 1.60990035 |
| 161 | Hand muscle atrophy (HP:0009130) | 1.60434626 |
| 162 | Annular pancreas (HP:0001734) | 1.60026583 |
| 163 | Lymphangioma (HP:0100764) | 1.58999732 |
| 164 | Spondylolisthesis (HP:0003302) | 1.58964653 |
| 165 | Failure to thrive in infancy (HP:0001531) | 1.58587076 |
| 166 | Interstitial pulmonary disease (HP:0006530) | 1.58556768 |
| 167 | Dilatation of the ascending aorta (HP:0005111) | 1.58370712 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAPK15 | 2.67137423 |
| 2 | TRIB3 | 2.60891184 |
| 3 | TGFBR2 | 2.45732296 |
| 4 | RIPK1 | 2.42592367 |
| 5 | ERN1 | 2.42222125 |
| 6 | CAMK1G | 2.11596508 |
| 7 | EPHB1 | 2.01475128 |
| 8 | DMPK | 1.93075714 |
| 9 | CAMK1D | 1.89024332 |
| 10 | EPHA3 | 1.81554984 |
| 11 | MAP4K1 | 1.80321304 |
| 12 | MAP3K9 | 1.75220722 |
| 13 | ICK | 1.67940108 |
| 14 | SIK1 | 1.61259995 |
| 15 | FGFR4 | 1.57661463 |
| 16 | PRKD3 | 1.54986525 |
| 17 | TNK2 | 1.53617950 |
| 18 | TTN | 1.50358141 |
| 19 | MAP3K7 | 1.34533963 |
| 20 | MAP3K10 | 1.29739875 |
| 21 | TYRO3 | 1.26656650 |
| 22 | MAP3K3 | 1.24285360 |
| 23 | CAMKK1 | 1.22281771 |
| 24 | DAPK2 | 1.22119866 |
| 25 | TAOK1 | 1.20444804 |
| 26 | CDK12 | 1.18500875 |
| 27 | FGFR3 | 1.16897600 |
| 28 | EEF2K | 1.16465535 |
| 29 | SIK2 | 1.14978939 |
| 30 | PRKCH | 1.14584026 |
| 31 | JAK1 | 1.12636583 |
| 32 | PKN2 | 1.10565595 |
| 33 | FGFR2 | 1.09693080 |
| 34 | MARK2 | 1.09559888 |
| 35 | TIE1 | 1.08900218 |
| 36 | PAK6 | 1.07604728 |
| 37 | OBSCN | 1.05017164 |
| 38 | MAP3K2 | 1.04458395 |
| 39 | PTK6 | 1.02351274 |
| 40 | EPHA4 | 1.01945021 |
| 41 | SIK3 | 1.00484260 |
| 42 | MAP3K13 | 0.99540545 |
| 43 | IRAK1 | 0.99110248 |
| 44 | NLK | 0.98503601 |
| 45 | TRPM7 | 0.97649321 |
| 46 | STK11 | 0.96919084 |
| 47 | SGK3 | 0.96408200 |
| 48 | PDGFRA | 0.94505901 |
| 49 | ITK | 0.93730502 |
| 50 | BTK | 0.93479420 |
| 51 | IKBKB | 0.93174670 |
| 52 | KSR2 | 0.92629905 |
| 53 | RET | 0.91261409 |
| 54 | JAK3 | 0.90121833 |
| 55 | MARK3 | 0.89854251 |
| 56 | SMG1 | 0.89690683 |
| 57 | IRAK2 | 0.89667783 |
| 58 | RPS6KC1 | 0.89064816 |
| 59 | RPS6KL1 | 0.89064816 |
| 60 | INSRR | 0.89007583 |
| 61 | UHMK1 | 0.88591423 |
| 62 | TAOK2 | 0.87350705 |
| 63 | PDGFRB | 0.87228562 |
| 64 | WNK4 | 0.83721186 |
| 65 | STK38 | 0.83355147 |
| 66 | PRKD1 | 0.82501017 |
| 67 | NTRK3 | 0.82285630 |
| 68 | MAPK7 | 0.82074331 |
| 69 | NTRK2 | 0.82069302 |
| 70 | PIK3CG | 0.81908417 |
| 71 | KIT | 0.80985933 |
| 72 | WNK1 | 0.80437093 |
| 73 | TAOK3 | 0.80278058 |
| 74 | PHKG2 | 0.80143265 |
| 75 | PHKG1 | 0.80143265 |
| 76 | MAP3K1 | 0.79708049 |
| 77 | PRKD2 | 0.78673477 |
| 78 | IRAK4 | 0.77638477 |
| 79 | BLK | 0.77433890 |
| 80 | MAPK4 | 0.75026299 |
| 81 | PDK1 | 0.74625796 |
| 82 | HCK | 0.74040731 |
| 83 | JAK2 | 0.73774001 |
| 84 | RPS6KA6 | 0.73636474 |
| 85 | PTK2B | 0.72221111 |
| 86 | SGK494 | 0.72031045 |
| 87 | SGK223 | 0.72031045 |
| 88 | MAPK12 | 0.71906635 |
| 89 | BMX | 0.71860807 |
| 90 | CAMK4 | 0.71429366 |
| 91 | MAP2K3 | 0.70854195 |
| 92 | HIPK2 | 0.70789830 |
| 93 | PDPK1 | 0.70758708 |
| 94 | TYK2 | 0.70156583 |
| 95 | MTOR | 0.70052354 |
| 96 | SYK | 0.68578233 |
| 97 | IKBKE | 0.66521714 |
| 98 | CHUK | 0.64406445 |
| 99 | TBK1 | 0.64398958 |
| 100 | FES | 0.64313441 |
| 101 | DYRK1B | 0.63010105 |
| 102 | ALK | 0.61719944 |
| 103 | LCK | 0.61055903 |
| 104 | MAP3K14 | 0.60898784 |
| 105 | MAP3K11 | 0.60197707 |
| 106 | CDC42BPA | 0.59541784 |
| 107 | ZAP70 | 0.59031574 |
| 108 | CAMK1 | 0.56624057 |
| 109 | TXK | 0.56273956 |
| 110 | PRKAA2 | 0.55990041 |
| 111 | CDK5 | 0.55570750 |
| 112 | LMTK2 | 0.55543255 |
| 113 | BRD4 | 0.53972465 |
| 114 | PTK2 | 0.53837978 |
| 115 | PRPF4B | 0.53304713 |
| 116 | MAPK11 | 0.53265600 |
| 117 | CSK | 0.51813183 |
| 118 | MAP2K2 | 0.51577906 |
| 119 | RPS6KA2 | 0.51455887 |
| 120 | MAPK3 | 0.51126318 |
| 121 | PAK2 | 0.49686665 |
| 122 | MAPK8 | 0.49000965 |
| 123 | MAPK10 | 0.48880546 |
| 124 | RPS6KA1 | 0.48505846 |
| 125 | GSK3A | 0.48339789 |
| 126 | MOS | 0.48050960 |
| 127 | SGK2 | 0.47987643 |
| 128 | PASK | 0.47934849 |
| 129 | GRK6 | 0.45303711 |
| 130 | SGK1 | 0.43583250 |
| 131 | RIPK4 | 0.41893573 |
| 132 | MAP3K6 | 0.41680692 |
| 133 | KSR1 | 0.40846245 |
| 134 | PAK3 | 0.40506393 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 1.85208509 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.79310242 |
| 3 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.57899263 |
| 4 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.53514985 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.52982664 |
| 6 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.48216025 |
| 7 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.40952599 |
| 8 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.33705456 |
| 9 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.32434550 |
| 10 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.28011876 |
| 11 | Insulin resistance_Homo sapiens_hsa04931 | 1.23978845 |
| 12 | Renin secretion_Homo sapiens_hsa04924 | 1.22436766 |
| 13 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.22187648 |
| 14 | Insulin secretion_Homo sapiens_hsa04911 | 1.21972716 |
| 15 | Cocaine addiction_Homo sapiens_hsa05030 | 1.20335910 |
| 16 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.19344834 |
| 17 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.19303788 |
| 18 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.18187363 |
| 19 | * Circadian entrainment_Homo sapiens_hsa04713 | 1.17190341 |
| 20 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.16337180 |
| 21 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.14940580 |
| 22 | Olfactory transduction_Homo sapiens_hsa04740 | 1.14537865 |
| 23 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.14427658 |
| 24 | Salivary secretion_Homo sapiens_hsa04970 | 1.14165530 |
| 25 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.12889630 |
| 26 | Long-term potentiation_Homo sapiens_hsa04720 | 1.12212086 |
| 27 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.10719736 |
| 28 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.10359007 |
| 29 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.08631986 |
| 30 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.08415857 |
| 31 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.07450979 |
| 32 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.05285316 |
| 33 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.03391883 |
| 34 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.03332411 |
| 35 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.02211661 |
| 36 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.01711779 |
| 37 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.01684052 |
| 38 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.01033259 |
| 39 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.00745547 |
| 40 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.00593316 |
| 41 | MAPK signaling pathway_Homo sapiens_hsa04010 | 1.00578871 |
| 42 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.99583478 |
| 43 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.98205052 |
| 44 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.98077993 |
| 45 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.97616742 |
| 46 | Morphine addiction_Homo sapiens_hsa05032 | 0.96970304 |
| 47 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.96345978 |
| 48 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.95392314 |
| 49 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.94229606 |
| 50 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.93914707 |
| 51 | Malaria_Homo sapiens_hsa05144 | 0.93831668 |
| 52 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.92442266 |
| 53 | Hepatitis B_Homo sapiens_hsa05161 | 0.92412626 |
| 54 | * Circadian rhythm_Homo sapiens_hsa04710 | 0.92301791 |
| 55 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.92158354 |
| 56 | Influenza A_Homo sapiens_hsa05164 | 0.91765991 |
| 57 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.91283699 |
| 58 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.90943968 |
| 59 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.90789130 |
| 60 | Colorectal cancer_Homo sapiens_hsa05210 | 0.88462042 |
| 61 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.88073814 |
| 62 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.87703396 |
| 63 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.87298617 |
| 64 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.86332458 |
| 65 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.86216642 |
| 66 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.86042183 |
| 67 | Lysine degradation_Homo sapiens_hsa00310 | 0.85977794 |
| 68 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.85780555 |
| 69 | GABAergic synapse_Homo sapiens_hsa04727 | 0.84925318 |
| 70 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.83441893 |
| 71 | Platelet activation_Homo sapiens_hsa04611 | 0.82978615 |
| 72 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.82321151 |
| 73 | Focal adhesion_Homo sapiens_hsa04510 | 0.82300799 |
| 74 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.80930674 |
| 75 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.80750565 |
| 76 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.80451946 |
| 77 | Tuberculosis_Homo sapiens_hsa05152 | 0.80217855 |
| 78 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.80212212 |
| 79 | Bile secretion_Homo sapiens_hsa04976 | 0.79277200 |
| 80 | Allograft rejection_Homo sapiens_hsa05330 | 0.79275860 |
| 81 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.79089028 |
| 82 | Pertussis_Homo sapiens_hsa05133 | 0.79003475 |
| 83 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.78780745 |
| 84 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.78735297 |
| 85 | Glioma_Homo sapiens_hsa05214 | 0.77886092 |
| 86 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.77661249 |
| 87 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.77367294 |
| 88 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.77208321 |
| 89 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.77001699 |
| 90 | Endocytosis_Homo sapiens_hsa04144 | 0.76237167 |
| 91 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.75836706 |
| 92 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.75773725 |
| 93 | Measles_Homo sapiens_hsa05162 | 0.74641764 |
| 94 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.73126286 |
| 95 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.73116589 |
| 96 | Viral myocarditis_Homo sapiens_hsa05416 | 0.72813256 |
| 97 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.72807525 |
| 98 | Leishmaniasis_Homo sapiens_hsa05140 | 0.71831565 |
| 99 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.71248196 |
| 100 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.71059373 |
| 101 | Amoebiasis_Homo sapiens_hsa05146 | 0.70547854 |
| 102 | Hepatitis C_Homo sapiens_hsa05160 | 0.70275495 |
| 103 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.69850120 |
| 104 | Prion diseases_Homo sapiens_hsa05020 | 0.69641675 |
| 105 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.69441262 |
| 106 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.68384467 |
| 107 | HTLV-I infection_Homo sapiens_hsa05166 | 0.68018340 |
| 108 | Axon guidance_Homo sapiens_hsa04360 | 0.67127140 |
| 109 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.66303734 |
| 110 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.65972286 |
| 111 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.64751491 |
| 112 | Endometrial cancer_Homo sapiens_hsa05213 | 0.64409729 |
| 113 | Gap junction_Homo sapiens_hsa04540 | 0.63919802 |
| 114 | Prostate cancer_Homo sapiens_hsa05215 | 0.63769259 |
| 115 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.63113775 |
| 116 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.62149230 |
| 117 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.61479186 |
| 118 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.59917936 |
| 119 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.59637280 |
| 120 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.59133618 |
| 121 | Melanogenesis_Homo sapiens_hsa04916 | 0.57874987 |
| 122 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.57465730 |
| 123 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.57260744 |
| 124 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.57070836 |
| 125 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.56958886 |
| 126 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.56829754 |
| 127 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.56756674 |
| 128 | * Herpes simplex infection_Homo sapiens_hsa05168 | 0.56343022 |
| 129 | Adherens junction_Homo sapiens_hsa04520 | 0.55099123 |
| 130 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.54232649 |
| 131 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.51401564 |

